Prophylactic Anticoagulation Therapy: Comment on the Article by Henderson et al
暂无分享,去创建一个
[1] C. Linari,et al. SARS‐COV‐2–associated coagulopathy and thromboembolism prophylaxis in children: A single‐center observational study , 2020, Journal of Thrombosis and Haemostasis.
[2] L. Henderson,et al. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 2 , 2020, Arthritis & rheumatology.
[3] P. Monagle,et al. Consensus‐based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID‐19–related illness , 2020, Journal of Thrombosis and Haemostasis.
[4] David R. Holtgrave,et al. Multisystem Inflammatory Syndrome in Children in New York State , 2020, The New England journal of medicine.
[5] Simon Li,et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents , 2020, The New England journal of medicine.